Brief: Gadopiclenol Marketing Authorization Dossier Submissions Accepted For Review By EMA And FDA

Guerbet SA

29/03/2022 20:18

Guerbet SA  GRBT.PA :
    * GADOPICLENOL MARKETING AUTHORIZATION DOSSIER SUBMISSIONS
ACCEPTED FOR REVIEW BY EMA AND FDA
    * GUERBET SA -  US-FDA HAS ACCEPTED REQUEST FOR PRIORITY
REVIEW
WITH A GOAL DATE FOR TAKING ACTION ON AN APPLICATION BY
SEPTEMBER 21 FOR GADOPICLENOL

Source text for Eikon:  ID:nPn1nvYd5a 
Further company coverage:  GRBT.PA